Current cell and gene therapy products are estimated to cost >$250k per injection. This is unsustainable.
Our vision is to democratize access to cell therapy and provide benefits to a larger section of humanity
We intend to disrupt the global cell therapy ecosystem and set a new benchmark for quality and affordability in this sector.
Eyecyte-RPE-our flagship project to treat incurable macular degeneration has excellent efficacy results and will be in FIM trials in 2021.
Company Details
- Employees
- 19
- Address
- Centre For Cellular And Molecular Platforms, Gkvk Post,bellary Road,india
- Industry
- Biotechnology
- HQ
- Bangalore, KARNATAKA
Eyestem Research Questions
Eyestem Research's LinkedIn profile is https://in.linkedin.com/company/eyestem-research
Eyestem Research has
19 employees.
View email and phone details for 19
employees at Eyestem Research.
Eyestem Research's industry is
Biotechnology
Eyestem Research's top competitors are
Stempeutics Research Private Limited,
Bugworks Research Inc.,
Cygenica Ltd.,
Zumutor Biologics,
Gangagen Biotechnologies,
Nkure Therapeutics,
String Bio Private Limited,
Immuneel Therapeutics Pvt. Ltd.,
Sea6 Energy Pvt Ltd.,
Pandorum Technologies.
Eyestem Research's categories are Biotechnology
